Not Yet Recruiting
Ivonescimab Combined with Chemotherapy As First-line Treatment of Relapsed or Metastatic Thymic Cancer: a Prospective, Single Arm, Phase II Trial
NCT06750952
- Conditions
- Disease Attributes, First-line Treatment, Hemic and Lymphatic Diseases, +9 more
- Locations
-
Not specified